Addendum to IMC Submission on Drugs for Rare Diseases

Innovative Medicines Canada provides Health Canada with additional input regarding IMC’s March 2021 consultation submission on drugs for rare diseases.

resources

Discover. Learn.
Understand.

Informative content to keep you up to date on the most pressing issues facing our industry.